Candel Therapeutics Cash Flow Statement (2020-2025) | CADL

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
-4.67M-5.32M-8.04M-7.75M-9.16M-9.12M-9.06M-7.88M-9.53M-9.77M-9.03M-10.58M-8.23M-8.90M-9.01M-8.24M-7.50M-10.49M-12.41M-16.07M
Depreciation and Depletion (Quarter)
0.24M0.20M0.20M0.20M0.30M0.30M0.20M0.20M0.30M0.24M0.20M0.20M0.10M
Share-based Compensation (Quarter)
0.43M1.07M1.91M-0.45M0.49M0.44M0.74M0.63M0.73M0.73M0.69M0.94M1.04M1.84M1.18M1.24M0.31M1.05M1.16M1.29M
Gains from Sales and Divestitures (Quarter)
0.31M0.70M1.03M1.94M0.33M0.33M0.33M0.33M
Gains from Investment Securities (Quarter)
0.28M4.61M8.25M0.00M1.98M5.65M1.33M-2.74M0.06M6.42M6.06M1.57M-0.01M4.68M0.54M5.83M1.62M-5.69M-1.15M13.52M
Asset Writedowns and Impairment (Quarter)
0.23M0.04M0.00M0.01M
Non-cash Items (Quarter)
1.05M1.69M2.05M2.47M2.41M2.68M0.88M3.06M3.25M3.48M0.20M3.50M3.39M20.30M27.60M13.85M3.73M11.39M4.10M
Cash from Operations (Quarter)
-5.63M-4.46M-6.89M-5.24M-8.05M-7.10M-9.38M-6.88M-10.82M-7.20M-8.81M-7.42M-8.44M-6.20M-6.57M-5.81M-8.62M-8.89M-10.24M-10.57M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.03M0.01M0.02M0.18M0.17M0.19M0.20M0.18M0.23M0.24M0.20M0.30M0.30M0.20M0.20M0.30M0.24M0.20M0.20M0.10M
Change in Working Capital
Change in Account Payables (Quarter)
0.17M-0.35M0.18M0.67M-0.58M0.42M-0.51M-0.54M0.15M-0.06M-0.21M0.17M0.05M-0.04M-0.14M-0.06M0.51M1.01M-0.74M0.03M
Change in Accured Expenses (Quarter)
-1.27M0.05M0.81M0.72M0.09M0.19M0.55M0.43M-1.79M0.63M-0.09M0.95M-1.58M0.44M1.35M0.54M-2.37M1.12M1.21M2.29M
Investing Activities
Capital Expenditures (Quarter)
1.85M-0.91M0.39M0.50M0.42M0.39M-0.55M-0.19M0.07M0.24M0.10M0.05M0.01M0.01M-0.01M0.01M0.02M-0.00M0.17M-0.05M
Sales of Property, Plant and Equipment (Quarter)
0.16M0.02M
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)
-0.23M-0.71M-0.39M-0.50M-0.17M-0.64M-0.21M-0.28M0.02M-0.17M-0.10M-0.03M-0.01M-0.01M-0.00M-0.00M-0.03M-0.12M-0.41M
Financing Activities
Other financing activities (Quarter)
-0.18M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
19.91M
Long-Term Debt Repayments (Quarter)
-1.67M-2.50M-2.50M-2.50M-2.50M-2.50M-2.50M-4.23M
Change in Capital Stock
Shares Issued (Quarter)
0.04M71.30M-70.91M0.01M0.02M0.04M0.23M3.42M-2.32M0.37M0.38M0.11M4.55M-4.52M
Misc.
Cash from Financing Activities (Quarter)
0.11M0.33M71.36M19.92M0.02M0.04M-0.12M-1.25M1.95M1.68M91.91M-1.87M17.44M-3.37M43.90M
Change in Cash (Quarter)
-5.74M-4.84M64.07M-5.74M11.69M-7.71M1.64M-18.36M-10.80M-7.36M-8.91M-7.57M-9.70M-4.26M-4.90M86.10M-10.49M8.52M-13.72M32.92M
Free Cash Flow (Quarter)
-7.48M-3.55M-7.29M-5.74M-8.47M-7.48M-8.84M-6.69M-10.88M-7.44M-8.91M-7.47M-8.45M-6.20M-6.56M-5.83M-8.63M-8.89M-10.40M-10.52M
Net Cash Flow (Quarter)
-5.74M-4.84M64.07M-5.74M11.69M-7.71M-9.60M-7.12M-10.80M-7.36M-8.91M-7.57M-9.70M-4.26M-4.90M86.10M-10.49M8.52M-13.72M32.92M